Updated: May 24, 2026

Rescue of Recombinant Newcastle Disease Virus from cDNA
Published on: October 11, 2013
M Boorsma1, D Koller, W A Renner
1Cytos Biotechnology AG, Wagistrasse 21, CH-8952, Zurich-Schlieren, Switzerland.
Alphavirus vectors offer high-level protein production for gene therapy and vaccine development. New non-cytopathic and inducible vectors enhance bioprocess strategies and gene discovery.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: